Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
DNA damage responses (DDR) occur during oncogenesis and therapeutic responses to DNA damaging cytotoxic drugs. Thus, a real-time method to image DNA damage in vivo would be useful to diagnose cancer and monitor its treatment. Toward this end, we have developed fluorophore- and radioisotope-labeled i...
Main Authors: | Cornelissen, B, Kersemans, V, Darbar, S, Thompson, J, Shah, K, Sleeth, K, Hill, M, Vallis, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Association for Cancer Researc
2011
|
Similar Items
-
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
by: Cornelissen, B, et al.
Published: (2012) -
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
by: Cornelissen, B, et al.
Published: (2012) -
PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.
by: Knight, J, et al.
Published: (2015) -
Effect of prolonging radiation delivery time on retention of gammaH2AX
by: Duzenli Cheryl, et al.
Published: (2008-06-01) -
PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates
by: Knight, J, et al.
Published: (2015)